TERNS PHARMACEUTICALS, INC., SC TO-T filed on 4/7/2026
Tender offer statement by Third Party
v3.26.1
Submission
Apr. 06, 2026
Submission [Line Items]  
Central Index Key 0000310158
Registrant Name Merck & Co., Inc.
Form Type SC TO
Submission Type SC TO-T
Fee Exhibit Type EX-FILING FEES
Offering Table N/A
Offset Table N/A N/A
v3.26.1
Offerings - Offering: 1
Apr. 06, 2026
USD ($)
Offering:  
Fee Previously Paid false
Rule 0-11 true
Transaction Valuation $ 6,729,179,680.00
Fee Rate 0.01381%
Amount of Registration Fee $ 929,299.71
Offering Note Estimated solely for purposes of calculating the filing fee. The transaction valuation was calculated by adding (a) the product of (i) $53.00 (the "Offer Price") and (ii) 115,458,298 Shares issued and outstanding, (b) the product of (i) 12,925,730 Shares pursuant to outstanding options granted and outstanding under equity plans and (ii) the excess of the Offer Price over $10.40 (the weighted average exercise price of such options) and (c) the product of (i) 1,117,996 restricted stock units and (ii) the Offer Price. The calculation of the filing fee is based on information provided by Terns as of April 2, 2026. The filing fee was calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory for Fiscal Year 2026, effective October 1, 2025, by multiplying the transaction value by 0.00013810.
v3.26.1
Fees Summary
Apr. 06, 2026
USD ($)
Fees Summary [Line Items]  
Previously Paid Amount $ 0.00
Total Fee Amount 929,299.71
Total Transaction Valuation 6,729,179,680.00
Total Offset Amount 0.00
Net Fee $ 929,299.71